Skip to main content
. Author manuscript; available in PMC: 2011 Oct 15.
Published in final edited form as: Biochem Pharmacol. 2010 Jun 30;80(8):1238–1251. doi: 10.1016/j.bcp.2010.06.040

Table 3.

Maximal HS and LS ACh-Stimulated 86Rb+ Efflux and Cytisine-Sensitive [125I]Epibatidine Binding in Cortex and Thalamus of Mice Chronically Treated with Nicotine

Nicotine Infusion Dose 0.0 mg/kg/hr 0.5 mg/kg/hr 4.0 mg/kg/hr
CORTEX
High Sensitivity 86Rb+ Efflux 2.11±0.11 2.06±0.19 1.88±0.11
Low Sensitivity 86Rb+ Efflux 6.81±0.59 6.80±0.50 5.63±0.80
[125I]-Epibatidine Bound 88.2±0.7 127.9±1.1 139.0±1.2
THALAMUS
High Sensitivity 86Rb+ Efflux 13.07±0.89 10.19±0.99 6.76±1.19
Low Sensitivity 86Rb+ Efflux 16.26±1.27 13.84±2.48 12.52±1.96
[125I]-Epibatidine Bound 198.4±2.7 240.7±2.5 256.8±2.9

HS and LS ACh-stimulated 86Rb+ efflux were calculated as described in the Methods. Values represent mean ± SEM for 9-11 individual experiments for Cortex and 7 individual experiments for Thalamus. 86Rb+ efflux data are presented as total efflux normalized to baseline. [125I]Epibatidine binding is given as fmol/mg protein.